Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 1
2001 4
2002 3
2003 7
2004 4
2005 3
2006 2
2007 1
2008 2
2009 2
2010 2
2011 3
2012 5
2013 7
2014 4
2015 3
2016 3
2017 7
2018 5
2019 6
2020 9
2021 6
2022 11
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 14584002

101 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous immunoglobulin for the treatment of Kawasaki disease in children.
Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Oates-Whitehead RM, et al. Cochrane Database Syst Rev. 2003;2003(4):CD004000. doi: 10.1002/14651858.CD004000. Cochrane Database Syst Rev. 2003. PMID: 14584002 Free PMC article. Review.
Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T. Broderick C, et al. Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2. Cochrane Database Syst Rev. 2023. PMID: 36695415 Free PMC article. Review.
Salicylate for the treatment of Kawasaki disease in children.
Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS. Baumer JH, et al. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004175. doi: 10.1002/14651858.CD004175.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054199 Free PMC article. Review.
TNF-α blockers for the treatment of Kawasaki disease in children.
Yamaji N, da Silva Lopes K, Shoda T, Ishitsuka K, Kobayashi T, Ota E, Mori R. Yamaji N, et al. Cochrane Database Syst Rev. 2019 Aug 16;8(8):CD012448. doi: 10.1002/14651858.CD012448.pub2. Cochrane Database Syst Rev. 2019. PMID: 31425625 Free PMC article.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Cochrane Database Syst Rev. 2014. PMID: 25238327 Free PMC article. Review.
Corticosteroids for the treatment of Kawasaki disease in children.
Wardle AJ, Connolly GM, Seager MJ, Tulloh RM. Wardle AJ, et al. Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2. Cochrane Database Syst Rev. 2017. PMID: 28129459 Free PMC article. Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002063. doi: 10.1002/14651858.CD002063.pub5. Cochrane Database Syst Rev. 2012. PMID: 22786476 Updated. Review.
101 results